Company intelligence / Profile preview

Ventric Health

Pasadena/Los Angeles area, California, United States

Ownership: Private
Development stage: Other

Overview

Vivio is FDA-cleared for non-invasive detection of elevated LVEDP, enabling early diagnosis of heart failure in primary care; data show improved prescription rates and earlier patient intervention. Over 15,000 tests performed, demonstrating improved patient outcomes and reduced hospitalizations

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Value-based care organization partnerships (primary care, physician groups)

Beyond the preview

Go deeper on Ventric Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventric Health.

Explore the full profile